Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of PS Therapy Tear Substitutes in Moderate Dry Eye Disease
NCT06633471Phase 1Not yet recruiting
- Sponsor
- PS Therapy
- Start
- Nov 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in dry eye disease (DED) (4 arms), sponsored by PS Therapy. Primary endpoints: Schirmer's Test Score at 4 weeks, Tear Film Break Up Time at 4 weeks and 3 more. Planned start Nov 2024; status: not yet recruiting.
02
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06633471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06633471.